NEWS NEWS IN BRIEF


PHARMACY SHOW 2015 The Pharmacy Show, now in its 9th year, returns to the NEC, Birmingham on Sunday 18th and Monday 19th October.


Pharmacy owners and their teams together with pharmacy buyers, wholesalers and allied professionals are invited to take part in two unique days of product sourcing, learning and networking at the UK's leading exhibition and conference dedicated to pharmacy in the community.


As the NHS moves towards placing a greater role on community in the delivery of patient care, visitors can expect exciting new developments as the show's education programme evolves to meet the needs and future shape of community pharmacy.


Eight key conference streams in 2015; Clinical, Business, Local Pharmacy Innovation, Public Health & Wellbeing, Keynote and new for this year the Pharmaceutical Care Skills Theatre with MUR Workshops and the Technology Hub giving you plenty of opportunity to top up your CPD.


After the success of exhibiting at the pharmacy show 2014, Clover 51 will be returning this year.


This will be the company’s third year in attendance at what is the Premier pharmacy show in the UK. “It gives us an opportunity to show what a Local company has to offer the rest of the UK and Ireland in technologically advanced robotic solutions,” says Clover 51 Director Steven Graham.


“Our manufacturing partners are market leaders and the pharmacy show gives us an opportunity to demonstrate and educate pharmacies on how our solutions can help improve their business. We will again have our blister tray packing machine – Synmed along with our Evotec dispensing robot and retail vending solutions.”


Those attending the show, can book an appointment with Clover 51 by calling their office on 028 2585 8424.


Alliance staff raise £40k for cancer research


Alliance Healthcare staff, in association with Accord Healthcare Limited, hit the netball court and the football field in a staff competition in Nottingham last weekend, to raise £40,000 for cancer research.


More than 300 staff, family, supporters and Alliance Healthcare partners attended the day, with 23 football and 4 netball teams from across the UK competing.


The championship is part of a wider partnership initiative between Walgreens Boots Alliance and the European Organisation for Research and Treatment of Cancer Research Fund (EORTC Cancer Research Fund), to raise funds for the EORTC SPECTAcolor Biobank project – the Screening Platform for Clinical Trials in Advanced Colorectal Cancer. Each year, colorectal cancer – cancer of the


colon and rectum – is responsible for over 220,000 deaths across Europe and is ranked as the third highest cause of death in the UK.


In an advanced stage, the average life expectancy beyond diagnosis in fatal cases is estimated to be two-three years. Many of these lives could be saved with early detection and treatment.


The Biobank stores biological samples of tumours from people with colorectal cancer for use in research to help understand the cancer better, in order to help develop a cure. So far,


more than 600 people have enrolled for the Biobank.


Alliance Healthcare has sponsored the EORTC since 2012. The sports championship is the main UK sponsorship event, with teams raising money to take part by holding cakes sales, car washes, raffles, and other events. The rest of the donations come from sponsorship from Alliance Healthcare’s manufacturer and support partners.


This year’s football winners were from the Hinckley Service Centre and the netball winners were from the Croydon Service Centre.


Views sought on new investigating committee guidance


The General Pharmaceutical Healthcare Council has launched a consultation on new guidance for the investigating committee to use when deciding what outcome is appropriate in a fitness to practise case.


Good decision making: investigating committee meetings and outcomes guidance explains the role of the investigating committee and how it decides whether a case should be considered by the fitness to practise committee.


The GPhC wants to hear from pharmacy professionals, representative bodies, patients and committee members themselves, to get their views on the guidance. Commenting on the launch of the


20 - SCOTTISH PHARMACIST


consultation, Duncan Rudkin, Chief Executive of the GPhC, said, “The investigating committee is a vital decision making body at an important point in the fitness to practise process. We want to ensure that members of the investigating committee continue to be supported by up to date guidance which clearly sets out the decision-making framework and the outcomes they can decide on.


“Legally the committee must sit in private and so it is essential that the final guidance sets out how members must make their decisions, to provide transparency about the process and give people confidence that the decisions taken are consistent, fair and proportionate.”


The investigating committee operates independently of the GPhC but must take account of guidance produced by the GPhC to support consistent, fair and proportionate decision-making.


This guidance is aimed at everyone who is involved in an investigating committee meeting, has made a complaint about a registrant or has had a complaint about them referred to an IC meeting.


This includes GPhC staff, IC members, registrants and their representatives. It will also be useful to anyone who is interested in the fitness to practise process, including patients and their representatives.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48